Tissue transglutaminase: a possible role in neurodegenerative diseases.
about
Transglutaminases: nature's biological gluesCystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's diseaseStructural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activityCerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?Tissue transglutaminase contributes to disease progression in the R6/2 Huntington's disease mouse model via aggregate-independent mechanismsCystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells.Screening for transglutaminase-catalyzed modifications by peptide mass finger printing using multipoint recalibration on recognized peaks for high mass accuracyBrain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canis in mice.Effect of choline-containing phospholipids on transglutaminase activity in primary astroglial cell cultures.Mathematical modeling of polyamine metabolism in mammals.Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site.Significant association of estrogen receptor binding site variation with bipolar disorder in females.Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamineBiogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications.Transglutaminase 2: a molecular Swiss army knife.Pathogenic factors in vascular dementia and Alzheimer's disease. Multiple actions of heparin that probably are beneficial.Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiationTransglutaminase and polyamination of tubulin: posttranslational modification for stabilizing axonal microtubulesTissue transglutaminase expression and activity in normal and glaucomatous human trabecular meshwork cells and tissues.TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cellsTissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits.Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views.Recent advances in understanding the roles of transglutaminase 2 in alcoholic steatohepatitis.Tissue transglutaminase, inflammation, and cancer: how intimate is the relationship?"Activation of tissue tranglutsaminase by removal of carboxyl-terminal peptides".Crystallization and preliminary X-ray crystallographic studies of transglutaminase 2 in complex with Ca2+.Effect of Some Growth Factors on Tissue Transglutaminase Overexpression Induced by β-Amyloid in Olfactory Ensheathing Cells.Structural aspects of transglutaminase 2: functional, structural, and regulatory diversity.GTP-binding-defective forms of tissue transglutaminase trigger cell death.Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.Phosphorylation of histones by tissue transglutaminase.Intracellular localization and activity state of tissue transglutaminase differentially impacts cell death.Post-translational modification of the hepatitis C virus core protein by tissue transglutaminase.Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis.Detection of transglutaminase activity using click chemistry.Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells.Phosphoinositide 3-kinase activity is required for retinoic acid-induced expression and activation of the tissue transglutaminase.Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner.
P2860
Q24534936-3A9E85B9-F948-4EA2-A513-7B9A1D030B69Q24548047-309CCED2-DCE5-4C34-9303-51BBE1CB3B9DQ24618141-9A70FBE0-A2ED-4C04-AC8E-854C5F744173Q27638096-7D2953C1-568D-4CFD-9229-284A108E7F83Q27693854-050911BA-DDE4-454C-91B7-71422B859D5EQ28592026-0A4127C5-4C24-4E14-915A-265DD31FD9C6Q31160300-41CBD110-DAC4-4D97-BA0F-17C1D2DE35C0Q33233251-556723F1-E995-4960-96C3-FFBAAD0C799FQ33345929-A9567C40-B31C-4626-B6FD-C9BFC4540863Q33385701-47277BA4-6422-4274-9A1F-E23B24A49A58Q33995976-258FD3AF-5FB4-48B0-8E6F-55F561F99BB8Q34142460-ADE7D8BC-A32F-41D8-893C-BE57654F2CD9Q34184540-D3A0C116-0293-4372-9F2F-ED8D471B86E7Q34805750-A34A40EA-B0AB-4260-BB8E-2E9255969764Q35086731-A4804B34-CBE2-4B70-BCE7-70A8F7014257Q35693361-269437D3-A6F6-4CF4-A353-0F72C2CBFB4FQ35852208-0A834A22-6F9D-4DAF-9E52-15F1CE0B4000Q36711191-F26D1C6E-711F-4A1C-8C19-F766FBA38C24Q36768195-F2AEBEAF-7186-48CE-9E48-352C5B9CFEE0Q37111745-7EAB6F48-8A1F-41F4-A4C7-3C632447B3EBQ37187694-AC970FA0-2C2B-45D9-9BE7-15FB92B9D1E7Q37195530-36E1CCD4-A142-4865-8F6D-3E1925CD46A5Q37266151-3992D2A0-54C1-41FA-BE97-026E77BD8421Q37700761-A8E67A37-C4EA-4EC4-B964-3AA0524CBB2FQ37956221-D49F0DA7-0A2E-4E1E-AE59-CC6D1114BF90Q38333306-D8068542-66B6-4C81-93E7-8B99CDA9AA46Q38618937-204434D4-3E62-4C84-90FC-E7158E4700D8Q39273075-C3B4857B-FD8F-47FD-9F14-255E348B41F9Q39414447-288DA4DC-2E0E-4A72-9AC4-1B42292BE8E1Q40041960-0E0DFFDD-DEA0-4342-BE9B-15FF069BDF95Q40214283-D633D31C-E8DB-4B15-AB52-CDA09C8EF697Q40290417-FEAF4DBC-F7A6-40DE-ACCC-72C5C1F83055Q40331106-25364FDE-7CFB-4FDA-BD33-EDEBFB008769Q40608257-B3F43F55-D442-4BA1-9A00-021A15BC5C02Q40773880-99A80C10-FCCF-43C2-8DA5-49E8C651B106Q40794709-2B5FC4C5-0364-4FE8-B3E6-9D5A084511C8Q41830794-FFF18C4F-2937-492A-8808-349B6CD36B18Q42437494-67E14745-B870-42AC-8C95-881831D3A939Q42818445-7ABB17C4-8D08-4F84-B880-B77D26664B00Q44028749-333BD39F-A708-4C24-930F-F0D3523F91B7
P2860
Tissue transglutaminase: a possible role in neurodegenerative diseases.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Tissue transglutaminase: a possible role in neurodegenerative diseases.
@ast
Tissue transglutaminase: a possible role in neurodegenerative diseases.
@en
type
label
Tissue transglutaminase: a possible role in neurodegenerative diseases.
@ast
Tissue transglutaminase: a possible role in neurodegenerative diseases.
@en
prefLabel
Tissue transglutaminase: a possible role in neurodegenerative diseases.
@ast
Tissue transglutaminase: a possible role in neurodegenerative diseases.
@en
P2093
P1476
Tissue transglutaminase: a possible role in neurodegenerative diseases.
@en
P2093
P304
P356
10.1016/S0301-0082(99)00052-0
P577
2000-08-01T00:00:00Z